HEPATITIS C NEW DRUG PIPELINE

NEW DRUG INDEX

Boceprevir (SCH 503034)

Schering - Protease inhibitor

Description:

Boceprevir also known as SCH 5034 is an oral protease inhibitor. It is being developed by Schering-Plough for the treatment of Hepatitis C.

Clinical Trial Milestones:

Phase II trials started in 2005.

  • Top
  • Login
  • Register

HCV New Drug Pipeline |  New Drug Index

This site is not affiliated in any way with any pharmaceutical company and does not endorse any treatment, product or investment. This information has been gathered from public sources, accuracy is not guaranteed. Please submit any comments, additions or error corrections.